Pacira Biosciences
PCRX
#5531
Rank
NZ$2.59 B
Marketcap
NZ$64.92
Share price
0.04%
Change (1 day)
58.35%
Change (1 year)
Categories

Operating Margin for Pacira Biosciences (PCRX)

Operating Margin as of November 2026 (TTM): 2.36%

According to Pacira Biosciences 's latest financial reports and stock price the company's current Operating Margin is 2.36%. At the end of 2022 the company had an Operating Margin of 7.99%.

Operating Margin history for Pacira Biosciences from 2010 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
20227.99%-50.92%
202116.28%49.71%
202010.87%255.44%
20193.06%-52.06%
20186.38%-174.89%
2017-8.52%-23.5%
2016-11.14%-381.71%
20153.95%-248.44%
2014-2.66%-96.01%
2013-66.74%-48.32%
2012-129.14%-43.85%
2011-229.98%49.7%
2010-153.63%-19.24%
2009-190.24%-41.6%
2008-325.77%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Zogenix
ZGNX
-259.55%-11,097.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
4.99% 111.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-467.67%-19,916.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-3,450.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-22.52%-1,054.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-879.80%-37,379.66%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.